Home › Test Catalogue › Infectious Diseases
Polymerase Chain Reaction
Pathogen panels built to CMS coverage policy.
Not to what a panel could theoretically include. Fewer denials, cleaner claims, less time your staff spends on appeals.
Panels
What we run.
- Urinary Tract Infection (UTI) Panel
- Respiratory Pathogen Panel
- Wound Pathogen Panel
- Onychomycosis (Nail) Panel
- Ocular Pathogen Panel
- ENT Pathogen Panel
- Sexually Transmitted Infection (STI) Panel
- COVID-19 (SARS-CoV-2)
- Antimicrobial Resistance (AMR) Gene Detection
Why it matters
A denial is a clinical delay.
Coverage-aligned design
Panel composition is reviewed against current CMS coverage policy rather than assembled for breadth.
Antimicrobial stewardship
AMR gene detection supports targeted therapy rather than empiric escalation.
In-house, end to end
Amplification, analysis, and reporting all occur at the Denver facility on our certificate.
PLACEHOLDER — PCR Turnaround Times
Publish committed TAT in hours from specimen receipt. For infectious disease, this is the whole decision.